Horn David R.
Horn David R.'s purchase track record
Horn David R. has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2026 | FOCL | $48K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
FOCL ADRs See Minor Daily Fluctuations in US Trading. FOCL, an ADR of EDAP TMS S.A., is part of the European ADR group that moved slightly higher on Friday, lower on Thursday, and declined on Tuesday. The ADRs’ daily swings reflect broader market sentiment rather than company‑specific news. The stock remains near its 52‑week range and is trading above its 200‑day SMA.
Transaction History
| SEER | ▼ Sell | Open Market | 7,309 | $15K | 8/18/2026 | View on chart |
| FOCL | ▲ Buy | Open Market | 10,000 | $48K | 8/14/2026 | View on chart |
| SEER | ▼ Sell | Open Market | 7,303 | $12K | 5/20/2026 | View on chart |
| SEER | ▼ Sell | Open Market | 7,743 | $15K | 2/18/2026 | View on chart |
| SEER | ▲ Buy | Grant | 79,000 | $0 | 2/3/2026 | View on chart |
| SEER | ▼ Sell | Open Market | 6,797 | $13K | 11/19/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 6,827 | $14K | 8/20/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 6,760 | $14K | 5/20/2025 | View on chart |
| SEER | ▼ Sell | Tax Withholding | 26,572 | $61K | 2/18/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 3,550 | $8K | 2/4/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 12,684 | $20K | 2/22/2024 | View on chart |
| SEER | ▲ Buy | Grant | 165,038 | $0 | 2/6/2024 | View on chart |
| SEER | ▼ Sell | Open Market | 3,608 | $6K | 2/5/2024 | View on chart |
| SEER | ▼ Sell | Open Market | 5,951 | $25K | 2/21/2023 | View on chart |
| SEER | ▲ Buy | Grant | 70,000 | $0 | 2/15/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 3,124 | $17K | 2/7/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 2,602 | $13K | 1/17/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 18,884 | $124K | 12/8/2022 | View on chart |
| SEER | ▲ Buy | Grant | 62,000 | $0 | 2/8/2022 | View on chart |
| SEER | ▼ Sell | Open Market | 2,944 | $51K | 2/2/2022 | View on chart |
| SEER | ▼ Sell | Open Market | 2,308 | $53K | 1/3/2022 | View on chart |
| SEER | ▲ Buy | Option Exercise | 28,818 | $100K | 12/7/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 26,273 | $532K | 12/6/2021 | View on chart |
| SEER | ▲ Buy | Option Exercise | 10,000 | $27K | 11/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 6,112 | $229K | 11/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 3,888 | $149K | 11/1/2021 | View on chart |
| SEER | ▲ Buy | Option Exercise | 10,000 | $27K | 10/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 4,964 | $166K | 10/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 5,036 | $173K | 10/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 9,299 | $368K | 9/1/2021 | View on chart |
| SEER | ▼ Sell | Open Market | 701 | $28K | 9/1/2021 | View on chart |
| SEER | ▲ Buy | Option Exercise | 10,000 | $27K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced
Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.